乳腺癌发生腋窝外三角组织转移特点与影响因素分析

doi:10.11904/j.issn.1002-3070.2022.03.006

摘要/Abstract

摘要： 目的评估外三角组织转移的相关因素,筛选外三角组织转移率低的人群,探讨外三角组织保留的意义。方法选取2020年9月—2021年6月于哈尔滨医科大学附属肿瘤医院行腋窝淋巴结清扫术(Axillary lymph node dissection,ALND)的患者150例进行回顾性研究,将患者以行或未行新辅助化疗(Neoadjuvant chemotherapy,NAC)为标准分组,其中未接受NAC患者95例,接受NAC患者55例。分析临床资料和外三角组织转移的相关性,筛选外三角组织转移的影响因素,绘制ROC曲线评价联合诊断预测外三角组织转移的效果。结果总样本中,22例患者有外三角组织转移。在未行NAC的95例患者中,外三角淋巴结中位数为3.0枚,外三角组织转移19例(20%),彩超腋窝淋巴结尺寸与外三角组织转移相关(P=0.011)。多因素logistic回归分析显示年龄≤55岁、淋巴结较大、PR阳性是外三角组织转移的独立影响因素。ROC曲线分析显示联合诊断的曲线下面积为0.820,特异性为77.8%,敏感性为78.7%。在55例行NAC患者中,外三角组织转移3例(5.5%)。结论淋巴结尺寸和pN分期是外三角组织转移的影响因素,接受NAC的乳腺癌患者可豁免外三角组织清扫。

关键词: 乳腺癌, 外三角组织, 腋窝淋巴结转移, 腋窝淋巴结清扫术

Abstract: Objective The aims of this study were to evaluate the risk factors of outer triangle tissue metastases,screen the patients with few outer triangle tissue metastases and discuss the significance of outer triangle tissue preservation. Methods A total of 150 patients underwent axillary lymph node dissection(ALND)in Harbin Medical University Cancer Hospital from September 2020 to June 2021 was conducted for this retrospective study.Patients were divided into two groups according to neoadjuvant therapy(NAC),with 95 patients in none NAC group and 55 patients in NAC group.The correlation between clinical data and outer triangle tissue metastases was analyzed.Multivariate logistic regression analysis was used to screen the risk factors and ROC curve was used to evaluate the combined diagnosis. Results In total sample,22 patients were detected outer triangle tissue metastases.Among 95 none NAC patients,19 patients(20%)had outer triangle tissue metastases.The size of lymph node in ultrasound was correlated with outer triangle tissue metastases(P=0.011).Multivariate logistic analysis showed that age ≤55 years,lymph node size and progesterone receptor condition were independent influencing factors for outer triangle tissue metastases.According to ROC analysis,the area under the curve was 0.820,specificity was 77.8%,sensitivity was 78.7%.Among 55 NAC patients,3 patients(5.5%)were detected outer triangle tissue metastases. Conclusion Lymph node size and pN stage are the influencing factors for outer triangle tissue metastases.Patients with NAC can be exempted from outer triangle tissue dissection.

Key words: Breast cancer, Outer triangle tissue, Axillary lymph node metastasis, Axillary lymph node dissection

中图分类号:

R737.9

杨子涵, 许守平, 庞达. 乳腺癌发生腋窝外三角组织转移特点与影响因素分析[J]. 实用肿瘤学杂志, 2022, 36(3): 226-232.

YANG Zihan, XU Shouping, PANG Da. Characteristics of breast cancer metastases to outer triangle tissue and its influencing factors[J]. Journal of Practical Oncology, 2022, 36(3): 226-232.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.03.006

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I3/226

参考文献

1 Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.
2 Millet A,Fuster CA,Lluch A,et al.Axillary surgery in breast cancer patients[J].Clin Transl Oncol,2007,9(8):513-520.
3 Johnson AR,Singhal D.Immediate lymphatic reconstruction[J].J Surg Oncol,2018,118(5):750-757.
4 Noguchi M,Inokuchi M,Noguchi M,et al.Axillary surgery for breast cancer:past,present,and future[J].Breast Cancer,2021,28(1):9-15.
5 Cuadrado GA,de Andrade MFC,Akamatsu FE,et al.Lymph drainage of the upper limb and mammary region to the axilla:Anatomical study in stillborns[J].Breast Cancer Res Treat,2018,169(2):251-256.
6 Castelo M,Hu SY,Dossa F,et al.Comparing observation,axillary radiotherapy,and completion axillary lymph node dissection for management of axilla in breast cancer in patients with positive sentinel nodes:a systematic review[J].Ann Surg Oncol,2020,27(8):2664-2676.
7 Boccardo F,Casabona F,De Cian F,et al.Lymphedema microsurgical preventive healing approach:a new technique for primary prevention of arm lymphedema after mastectomy[J].Ann Surg Oncol,2009,16(3):703-708.
8 Naoum GE.Quantifying the impact of axillary surgery and nodal irradiation on breast cancer related lymphedema and local tumor control long-term results from a prospective screening trial[J].J Clin Oncol,2020,38(29):3430-3438.
9 Voogd AC,Ververs JM,Vingerhoets AJ,et al.Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer[J].Br J Surg,2003,90(1):76-81.
10 Classe JM,Loaec C,Gimbergues P,et al.Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients:the ganea 2 study[J].Breast Cancer Res Treat,2019,173(2):343-352.
11 Thompson M,Korourian S,Henry-Tillman R,et al.Axillary reverse mapping(arm):a new concept to identify and enhance lymphatic preservation[J].Ann Surg Oncol,2007,14(6):1890-1895.
12 Dorogi B,Bukovszky B,Matrai T,et al.Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer:a cohort study of 933 cases[J].Eur J Surg Oncol,2019,45(2):103-109.
13 Wang L,Cohen JC,Devasenapathy N,et al.Prevalence and intensity of persistent post-surgical pain following breast cancer surgery:a systematic review and meta-analysis of observational studies[J].Br J Anaesth,2020,125(3):346-357.
14 Henry BM,Graves MJ,Pekala JR,et al.Origin,branching,and communications of the intercostobrachial nerve:A meta-analysis with implications for mastectomy and axillary lymph node dissection in breast cancer[J].Cureus,2017,9(3):e1101.
15 Huang S,Qiu P,Chen W,et al.Modified radical mastectomy for anterior thoracic nerve and intercostobrachial nerve protection(case report)[J].Gland Surg,2020,9(2):463-466.
16 Wischnewsky M,Schwentner L,Diessner JD,et al.Brenda-score,a highly significant,internally and externally validated prognostic marker for metastatic recurrence:Analysis of 10,449 primary breast cancer patients[J].Cancers(Basel),2021,13(13):3121.
17 Niinikoski L,Hukkinen K,Leidenius MHK,et al.Axillary nodal metastatic burden in patients with breast cancer with clinically positive axillary nodes[J].Br J Surg,2020,107(12):1615-1624.
18 Angarita S,Ye L,Runger D,et al.Assessing the burden of nodal disease for breast cancer patients with clinically positive nodes:hope for more limited axillary surgery[J].Ann Surg Oncol,2021,28(5):2609-2618.
19 Rosenberger LH,Ren Y,Thomas SM,et al.Axillary lymph node dissection in node-positive breast cancer:Are ten nodes adequate and when is enough,enough?[J].Breast Cancer Res Treat,2020,179(3):661-670.
20 Beaton L,Nica L,Tyldesley S,et al.Pet/ct of breast cancer regional nodal recurrences:an evaluation of contouring atlases[J].Radiat Oncol,2020,15(1):136.

[1]	何伟丹, 李志高. FSIP1促进乳腺癌细胞迁移和侵袭并导致患者不良预后[J]. 实用肿瘤学杂志, 2022, 36(3): 233-238.
[2]	刘欣欣, 姚欣卉, 孙跃峰, 缪美琪, 陈晶. 乳腺癌微环境中趋化因子CCL20作用的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 250-254.
[3]	杨姝娅, 刘文慧, 骆耐香. UCA1在乳腺癌中的研究现状和应用展望[J]. 实用肿瘤学杂志, 2022, 36(3): 263-267.
[4]	刘婉莹, 庞达. 乳腺浸润性微乳头状癌转移机制的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 268-272.
[5]	孙元元, 张苧之, 曹孟儒. 乳腺癌肺转移机制及治疗进展[J]. 实用肿瘤学杂志, 2022, 36(2): 173-177.
[6]	侯建勋, 王洪斌. 外泌体对乳腺癌诊疗一体化影响的研究进展[J]. 实用肿瘤学杂志, 2022, 36(2): 178-182.
[7]	陈赫, 王秋程, 程文. 自动乳腺超声诊断系统在乳腺癌方面的应用进展[J]. 实用肿瘤学杂志, 2022, 36(2): 193-196.
[8]	李伟华, 张广凤, 马骊骊, 何品, 王雯, 李顶夫. 基于TCGA数据库代谢相关基因构建乳腺癌预后模型[J]. 实用肿瘤学杂志, 2022, 36(1): 37-43.
[9]	曹世玉, 姜永冬. 基因表达与多基因检测以及生物标志物对Luminal A型乳腺癌预后的影响[J]. 实用肿瘤学杂志, 2022, 36(1): 89-93.
[10]	罗波, 张曲, 郑红梅, 梁新军, 周小妹, 吴新红. SRT联合拉帕替尼治疗HER2阳性乳腺癌脑转移疗效及预后分析[J]. 实用肿瘤学杂志, 2021, 35(6): 523-528.
[11]	史润泽, 李志高. 三阴性乳腺癌各亚型精准医疗策略研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 529-533.
[12]	李响, 胡洋, 张清媛. 肿瘤突变负荷作为乳腺癌免疫治疗的新兴生物标志物的研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 568-571.
[13]	周天虹, 顾秀瑛, 姚芳, 宋述铭. 乌鲁木齐市2014—2018年度乳腺癌筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(5): 391-395.
[14]	马补换, 刘彩霞. Jagged1促进乳腺癌发生发展及远处转移的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 452-457.
[15]	秦朝, 李江, 郑亚迪, 王飞, 曹巍, 许永杰, 余一雯, 赵亮, 于欣阳, 陈宏达, 任建松, 王勇, 李静, 李霓, 陈万青. 中国城市乳腺癌高危人群筛查依从性及其相关因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 291-296.